RBC Capital reiterates ConAgra stock rating on Q1 results
RBC Capital reiterated a Sector Perform rating and $14.00 price target for ConAgra Brands (CAG) after Q1 results. The stock is down 25% over the past year. Q1 organic sales were solid, but profitability was boosted by nonrecurring items. RBC noted challenges ahead, including pricing elasticity and inflation management. CAG reported Q1 adjusted EPS of $0.41, beating estimates, with revenue of $2.6B.
How this was made
The 30-second read
Why it matters
The mixed earnings outcome—beat on EPS but weaker sales outlook—creates uncertainty. Analysts are split, with some maintaining holds and others lowering targets, suggesting a near‑term volatility window.
Market read
The earnings release provides fresh data that could move CAG and influence the broader consumer staples sector.
What to watch
Potential upside from pricing flexibility and cost management could improve margins later in the year.
Background
ConAgra Brands (CAG) is a leading packaged foods company with a long dividend history. The Q1 fiscal 2027 results were released with an adjusted EPS of $0.41 versus $0.28 consensus, but guidance indicated a 2% organic sales decline for Q2.
Ticker impact
RBC reiterated a Sector Perform rating and $14 price target after ConAgra Brands reported Q1 fiscal 2027 earnings with adjusted EPS $0.41 beating estimates but guided a 2% organic sales decline for Q2.
likely modest downside as investors price in the sales decline guidance
The beat was driven by non‑recurring items; guidance signals slower growth, prompting sell pressure.
Market effects
Food & consumer staples sector may see slight pressure as a major player signals slower organic growth.
U.S. equities could see modest pullback in consumer staples indexes.
Limited; impact confined to U.S. market and sector.
Counterpoint
The earnings beat and dividend continuity could support a bounce if the market overreacts to guidance.
Key entities
- AnalystRBC Capital
Reiterated Sector Perform rating and $14 price target.
- AnalystStifel
Maintained Hold rating with $15 price target.
- AnalystBernstein
Lowered price target to $11, citing leverage concerns.
